Page values for "Vemurafenib"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 859,078 |
| _pageName | Page | Vemurafenib |
| _pageTitle | String | Vemurafenib |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Vemurafenib |
| Short_definition | String | Vemurafenib - (pronounced) (VEH-myoo-RA-feh spring) A drug used to treat Erdheim-Chester disease (a very rare form of histiocytosis) and advanced melanoma that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |